| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 24.28M | -4.49% |
| Operating expense | — | — |
| Net income | -31.29M | 69.69% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MEB.F returned +41.0% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -3.7% |
| 1 year | +41.0% |
| 5 years | +132.5% |
| All-time high | €37.56 (Oct 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in MEB.F would be worth today ›No. MedinCell S.A. has not paid a dividend in the past 12 months.
MedinCell S.A. is part of the Healthcare sector.
MedinCell S.A. has a market cap of 851.82M EUR, based on the latest quote.
